SARS-CoV-2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice

被引:2
|
作者
Fricke, Charlie [1 ]
Pfaff, Florian [2 ]
Ulrich, Lorenz [2 ]
Halwe, Nico Joel [2 ]
Schoen, Jacob [2 ]
Timm, Laura [1 ]
Hoffmann, Weda [1 ]
Rauch, Susanne
Petsch, Benjamin [3 ]
Hoffmann, Donata [2 ]
Beer, Martin [2 ]
Corleis, Bjoern [1 ]
Dorhoi, Anca [1 ]
机构
[1] Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany
[2] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany
[3] CureVac SE, Tubingen, Germany
关键词
K18-hACE2; SARS-CoV-2; variant of concern; immune response; compartmentalization; INFECTION; CELLS;
D O I
10.1002/eji.202250332
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Knowledge about early immunity to SARS-CoV-2 variants of concern mainly comes from the analysis of human blood. Such data provide limited information about host responses at the site of infection and largely miss the initial events. To gain insights into compartmentalization and the early dynamics of host responses to different SARS-CoV-2 variants, we utilized human angiotensin converting enzyme 2 (hACE2) transgenic mice and tracked immune changes during the first days after infection by RNAseq, multiplex assays, and flow cytometry. Viral challenge infection led to divergent viral loads in the lungs, distinct inflammatory patterns, and innate immune cell accumulation in response to ancestral SARS-CoV-2, Beta (B.1.351) and Delta (B.1.617.2) variant of concern (VOC). Compared to other SARS-CoV-2 variants, infection with Beta (B.1.351) VOC spread promptly to the lungs, leading to increased inflammatory responses. SARS-CoV-2-specific antibodies and T cells developed within the first 7 days postinfection and were required to reduce viral spread and replication. Our studies show that VOCs differentially trigger transcriptional profiles and inflammation. This information contributes to the basic understanding of immune responses immediately postexposure to SARS-CoV-2 and is relevant for developing pan-VOC interventions including prophylactic vaccines. Fricke et al. report on early immune responses to various SARS-CoV-2 variants in the K18-hACE2 mouse. Beta triggers recruitment of neutrophils and monocytes, whereas Delta depletes alveolar macrophages. Spike-specific T and B cells mutually control virus dissemination and growth in this model. These insights inform the development of pan-variant interventions. (Created with BioRender.com)image
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients
    Phadke, Varun K.
    Scanlon, Nicholas
    Jordan, Stanley C.
    Rouphael, Nadine G.
    CURRENT TRANSPLANTATION REPORTS, 2021, 8 (02) : 127 - 139
  • [42] Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis
    Thye, Angel Yun-Kuan
    Law, Jodi Woan-Fei
    Pusparajah, Priyia
    Letchumanan, Vengadesh
    Chan, Kok-Gan
    Lee, Learn-Han
    BIOMEDICINES, 2021, 9 (10)
  • [43] Neutralizing antibodies to SARS-CoV-2 variants of concern: a pediatric surveillance study
    Fraser, Douglas D.
    Singh, Devika
    Cela, Enis
    Patel, Maitray A.
    Assaf, Maysaa
    Quintero, Maritza
    Knauer, Michael
    Miller, Michael R.
    Bellini, Melina
    Li, Angela
    Hahn, Paul
    Hrek, Marta
    Cruz-Aguado, Jorge
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [44] Identification of druggable host dependency factors shared by multiple SARS-CoV-2 variants of concern
    Frasson, Ilaria
    Diamante, Linda
    Zangrossi, Manuela
    Carbognin, Elena
    Pieta, Anna Dalla
    Penna, Alessandro
    Rosato, Antonio
    Verin, Ranieri
    Torrigiani, Filippo
    Salata, Cristiano
    Dizanzo, Maria Paula
    Vaccaro, Lorenzo
    Cacchiarelli, Davide
    Richter, Sara N.
    Montagner, Marco
    Martello, Graziano
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2024, 16 (03)
  • [45] New variants of SARS-CoV-2
    Canton, Rafael
    De Lucas Ramos, Pilar
    Garcia-Botella, Alejandra
    Garcia-Lledo, Alberto
    Gomez-Pavon, Javier
    Gonzalez del Castillo, Juan
    Hernandez-Sampelayo, Teresa
    Cruz Martin-Delgado, Mari
    Martin Sanchez, Francisco Javier
    Martinez-Selles, Manuel
    Molero Garcia, Jose Maria
    Moreno Guillen, Santiago
    Rodriguez-Artalejo, Fernando
    Ruiz-Galiana, Julian
    Bouza, Emilio
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 (05) : 419 - 428
  • [46] SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naive and Pre-Immune Humans
    Forgacs, David
    Jang, Hyesun
    Abreu, Rodrigo B.
    Hanley, Hannah B.
    Gattiker, Jasper L.
    Jefferson, Alexandria M.
    Ross, Ted M.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [47] The interplay of drug therapeutics and immune responses to SARS-CoV-2
    Fumagalli, Valeria
    Iannacone, Matteo
    CELLULAR & MOLECULAR IMMUNOLOGY, 2024, 21 (02) : 197 - 200
  • [48] Approaches to evaluate the specific immune responses to SARS-CoV-2
    Lopez-Gomez, Ana
    Pelaez-Prestel, Hector F.
    Juarez, Ignacio
    VACCINE, 2023, 41 (43) : 6434 - 6443
  • [49] SARS-CoV-2 infection: Pathogenesis, Immune Responses, Diagnosis
    Malviya, Kapil Kumar
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2022, 16 (03): : 1425 - 1440
  • [50] Immune responses to SARS-CoV-2 in dialysis and kidney transplantation
    Cantarelli, Chiara
    Angeletti, Andrea
    Perin, Laura
    Russo, Luis Sanchez
    Sabiu, Gianmarco
    Podesta, Manuel Alfredo
    Cravedi, Paolo
    CLINICAL KIDNEY JOURNAL, 2022, 15 (10) : 1816 - 1828